Epidemiology and Field Site Development

Researchers interested in TB immunology, epidemiology, diagnosis and other areas related to TB vaccine clinical development and evaluation may be able to benefit from Aeras procedures, access to data and clinical samples collected by Aeras. First priority for all materials collected by Aeras in its epidemiology and vaccine clinical development studies must go to its TB vaccine R&D program. However, Aeras welcomes enquiries regarding availability of protocols and materials that may be of value for related research and for applying for grant support for such research.